Inura Medical AG is admitted to participate at the 2020 >>venture>> competition!
Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia. The Company’s innovative, patented proprietary formulation technology is designed to facilitate the effective penetration of drugs through the urethral mucosal lining and bladder to reach targeted tissues. In January this year, Inura Medical AG has moved into the HEMEX INCUBATOR in Liestal, Switzerland where Inura receives support by our dedicated team in the clinical and regulatory development.
For the 2020 edition >>venture>> will be awarding a total of CHF 510,000 thanks to the generous support of sponsors. Start-ups will be competing under 5 verticals: Health & Nutrition, Industrials & Engineering, ICT, Retail & Consumer Services, and Finance & Insurance. The program is supported by workshops and allows access to a large pool of mentors and coaches.
Hemex offers a 6-step incubation program where start-ups are coached all the way on their journey from “green to gold”. Start-ups can enter the program at any stage and benefit from tailored solutions. Hemex combines development and fundraising skills and offers a distinctive advantage when interacting with the investor community.